Back
Keros Therapeutics Vs. Krystal Biotech Industry Stock Comparison
Sell
35
KROS
Keros Therapeutics
Last Price:
52.47
Seasonality Move:
30.98%
Sell
31
KRYS
Krystal Biotech
Last Price:
184.19
Seasonality Move:
19.58%
Sell
35
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $52.48. The Score for KROS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Krystal Biotech (KRYS)
is a Sell
Is Krystal Biotech a Buy, Sell or Hold?
- The current Krystal Biotech [KRYS] share price is $184.19. The Score for KRYS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- KRYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $52.48
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
KRYS Stock Price Chart
What is Krystal Biotech's stock price today?
-
The Krystal Biotech share price today is $184.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRYS is experiencing slight selling pressure.
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.98 | Buy |
| Relative Strength Index (14 RSI): | 64.81 | Buy |
| Chaikin Money Flow: | -202734 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.1 - 49.46) | Buy |
| Bollinger Bands (100): | (44.86 - 54.46) | Buy |
KRYS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.3 | Sell |
| Relative Strength Index (14 RSI): | 40.33 | Sell |
| Chaikin Money Flow: | -1761 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (182.69 - 198.89) | Sell |
| Bollinger Bands (100): | (162.53 - 197.21) | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.5 | Buy |
| 20-day SMA: | 46.75 | Buy |
| 50-day SMA: | 47.14 | Buy |
| 200-day SMA: | 51.01 | Buy |
| 8-day EMA: | 49.69 | Buy |
| 20-day EMA: | 47.98 | Buy |
| 50-day EMA: | 47.99 | Buy |
| 200-day EMA: | 48.97 | Buy |
KRYS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 191.95 | Sell |
| 20-day SMA: | 193.18 | Sell |
| 50-day SMA: | 194.51 | Sell |
| 200-day SMA: | 157.56 | Buy |
| 8-day EMA: | 189.95 | Sell |
| 20-day EMA: | 192.59 | Sell |
| 50-day EMA: | 190.42 | Sell |
| 200-day EMA: | 163.59 | Buy |
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.41 per share, and a decrease next year of $0.43 per share.
Krystal Biotech Earnings Growth & KRYS Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.86 per share, an increase next quarter of $0.49 per share, an increase this year of $3.98 per share, and an increase next year of $2.05 per share.
Keros Therapeutics Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Krystal Biotech Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||